These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 238144)

  • 21. Diurnal variations in the motor activity of the rat: effects of inhibitors of the catecholamine synthesis.
    Lemmer B; Berger T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):251-6. PubMed ID: 567282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-aggressive action of dopamine-beta-hydroxylase inhibitors in mice.
    Ross SB; Ogren SO
    J Pharm Pharmacol; 1976 Jul; 28(7):590-2. PubMed ID: 8618
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
    Berkowitz BA; Arleth AJ; Sung CP; Kruse LI; DeWolf WE; Ohlstein EH
    J Pharmacol Exp Ther; 1988 Jun; 245(3):850-7. PubMed ID: 3385645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some characteristics of amnesia induced by FLA-63 an inhibitor of dopamine beta hydroxylase.
    Botwinick CY; Quartermain D; Freedman LS; Hallock MF
    Pharmacol Biochem Behav; 1977 May; 6(5):487-91. PubMed ID: 19771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
    Hollister AS; Breese GR; Cooper BR
    Psychopharmacologia; 1974 Mar; 36(1):1-16. PubMed ID: 4151923
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of catecholaminergic drugs upon memory storage processes in mice.
    Haycock JW; Van Buskirk R; McGaugh JL
    Behav Biol; 1977 Jul; 20(3):281-310. PubMed ID: 19010
    [No Abstract]   [Full Text] [Related]  

  • 27. The irritant properties of dopamine-beta-hydroxylase inhibitors in relation to their effects on L-dopa-induced locomotor activity.
    Dolphin A; Elliott PN; Jenner P
    J Pharm Pharmacol; 1976 Oct; 28(10):782-5. PubMed ID: 10378
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of disulfiram and sodium diethyldithiocarbamate on tyrosine and dopamine-beta-hydroxylases activities in rat brain and heart.
    Szmigielski A
    Pol J Pharmacol Pharm; 1975; 27(2):153-9. PubMed ID: 239395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of an inhibitor of dopamin-beta-hydroxylase on the acquistion and retention of four different avoidance tasks in mice.
    Izquierdo I; Beamish DG; Anisman H
    Psychopharmacology (Berl); 1979 May; 63(2):173-8. PubMed ID: 112636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some catecholamine inhibitors do not cause accumulation of nuclear estrogen receptors in rat hypothalamus and anterior pituitary gland.
    Blaustein JD; Brown TJ; McElroy JF
    Neuroendocrinology; 1986; 43(2):143-9. PubMed ID: 2873523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbamazepine decreases catecholamine turnover in the rat brain.
    Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L
    J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of dopamine-beta-hydroxylase inhibitors FLA-57 and FLA-63 on ethanol metabolism and aldehyde dehydrogenase activity in rats.
    Tottmar O; Hellström E; Holmberg K; Lindros KO
    Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):198-202. PubMed ID: 7136724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biphasic effect of chlorpromazine on rat paradoxical sleep: a study of dose-related mechanisms.
    Kafi S; Gaillard JM
    Eur J Pharmacol; 1978 Jun; 49(3):251-7. PubMed ID: 26579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
    Heffner TG; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The involvement of the catecholaminergic system in physostigmine-induced hyperactivity in rats.
    Egbe PC
    Arzneimittelforschung; 1982; 32(1):27-9. PubMed ID: 6460507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibitors of catecholamine biosynthesis (review of the literature)].
    Frantsuzova SB
    Farmakol Toksikol; 1973; 36(5):624-8. PubMed ID: 4150865
    [No Abstract]   [Full Text] [Related]  

  • 37. Morphine lethality in rats: effects of inhibitors of brain catecholamine synthesis and methylation.
    Davis WM; Khalsa JH
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):867-72. PubMed ID: 4148579
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
    Jonsson G; Sachs C
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):287-96. PubMed ID: 4144667
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors.
    Lokhandwala MF; Buckley JP
    J Pharmacol Exp Ther; 1978 Feb; 204(2):362-71. PubMed ID: 621670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.